Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably knee osteoarthritis.

A sedentary lifestyle, rising obesity levels, increased participation in sports, and inflammatory disorders are believed to ...

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

Genascence’s GNSC-001 for knee osteoarthritis receives US FDA regenerative medicine advanced therapy designation: Palo Alto, California Saturday, July 19, 2025, 16:30 Hrs [IST] ...

Patients with knee osteoarthritis who received metformin demonstrated significant reductions in knee pain and increased ...

Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the most undervalued small-cap stocks to buy according to analysts.

Individuals with vs without knee, hip, or hand OA were associated with a significantly increased risk for sleep apnea.

First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synov ...

Knee pain can have many causes, such as injuries, overuse, and arthritis. Over-the-counter and prescription medications as ...

The ankle's ability to regenerate cartilage uses the same mechanisms that enable some animals to grow new limbs, and it could ...

Both yoga and strengthening exercises performed for 24 weeks effectively reduce knee pain associated with osteoarthritis ...